Rabbit SMN2 Polyclonal Antibody | anti-SMN2 antibody

SMN2 Polyclonal Antibody

Cat. Num. AAA9431584

• Reactivity: Human, Mouse, Rat
• Applications: Western Blot, Immunohistochemistry, Immunofluorescence, Immunoprecipitation
• Purity: Affinity purification
• Synonyms: SMN2; Polyclonal Antibody; SMN2 Polyclonal Antibody; BCD541; C-BCD541; GEMIN1; SMNC; TDRD16B; survival motor neuron protein; anti-SMN2 antibody

• Host: Rabbit
• Reactivity: Human, Mouse, Rat
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: Affinity purification
• Form/Format: PBS with 50% glycerol, pH7.4
• Sequence Length: 294

• Applicable Applications for anti-SMN2 antibody: Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP)
• Application Notes: WB: 1:500-1:2000; IHC: 1:50-1:200; IF: 1:50-1:200; IP: 1:20-1:50
• Immunogen: Recombinant fusion protein of human SMN2 (NP_059107.1).
• Conjugation: Unconjugated
• Preparation and Storage: Store at -20 degree C. Avoid freeze/thaw cycles.

Western Blot (WB)

(Western blot analysis of extracts of various cell lines, using SMN2 antibody.)

Immunohistochemistry (IHC)

(Immunohistochemistry of paraffin-embedded rat heart using SMN2 antibody.)

Immunohistochemistry (IHC)

(Immunohistochemistry of paraffin-embedded human prostate using SMN2 antibody.)

Immunofluorescence (IF)

(Immunofluorescence analysis of U2OS cells using SMN2 antibody.)

Related Product Information for anti-SMN2 antibody

This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The telomeric and centromeric copies of this gene are nearly identical and encode the same protein. While mutations in the telomeric copy are associated with spinal muscular atrophy, mutations in this gene, the centromeric copy, do not lead to disease. This gene may be a modifier of disease caused by mutation in the telomeric copy. The critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer. Note that the nine exons of both the telomeric and centromeric copies are designated historically as exon 1, 2a, 2b, and 3-8. It is thought that gene conversion events may involve the two genes, leading to varying copy numbers of each gene. The full length protein encoded by this gene localizes to both the cytoplasm and the nucleus. Within the nucleus, the protein localizes to subnuclear bodies called gems which are found near coiled bodies containing high concentrations of small ribonucleoproteins (snRNPs). This protein forms heteromeric complexes with proteins such as SIP1 and GEMIN4, and also interacts with several proteins known to be involved in the biogenesis of snRNPs, such as hnRNP mu protein and the small nucleolar RNA binding protein. Four transcript variants encoding distinct isoforms have been described.

Product Categories/Family for anti-SMN2 antibody

Total protein Ab

NCBI and Uniprot Product Information

• NCBI GI #: 10937869
• NCBI Accession #: NP_059107.1
• NCBI GenBank Nucleotide #: NP_059107.1
• UniProt Accession #: Q16637
• Molecular Weight: 35kDa
• NCBI Official Full Name: survival motor neuron protein isoform d
• UniProt Protein Name: Survival motor neuron protein
• UniProt Gene Name: SMN1
• UniProt Synonym Gene Names: SMN; SMNT
• UniProt Entry Name: SMN_HUMAN

Uniprot Description

SMN: The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs. Defects in SMN1 are the cause of spinal muscular atrophy autosomal recessive type 1 (SMA1). Spinal muscular atrophy refers to a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. Autosomal recessive forms are classified according to the age of onset, the maximum muscular activity achieved, and survivorship. The severity of the disease is mainly determined by the copy number of SMN2, a copy gene which predominantly produces exon 7-skipped transcripts and only low amount of full-length transcripts that encode for a protein identical to SMN1. Only about 4% of SMA patients bear one SMN1 copy with an intragenic mutation. SMA1 is a severe form, with onset before 6 months of age. SMA1 patients never achieve the ability to sit. Defects in SMN1 are the cause of spinal muscular atrophy autosomal recessive type 2 (SMA2). SMA2 is an autosomal recessive spinal muscular atrophy of intermediate severity, with onset between 6 and 18 months. Patients do not reach the motor milestone of standing, and survive into adulthood. Defects in SMN1 are the cause of spinal muscular atrophy autosomal recessive type 3 (SMA3). SMA3 is an autosomal recessive spinal muscular atrophy with onset after 18 months. SMA3 patients develop ability to stand and walk and survive into adulthood. Defects in SMN1 are the cause of spinal muscular atrophy autosomal recessive type 4 (SMA4). SMA4 is an autosomal recessive spinal muscular atrophy characterized by symmetric proximal muscle weakness with onset in adulthood and slow disease progression. SMA4 patients can stand and walk. Belongs to the SMN family. 4 isoforms of the human protein are produced by alternative splicing.

Protein type: RNA-binding; RNA processing

Chromosomal Location of Human Ortholog: 5q13.2

Cellular Component: nucleoplasm; spliceosome; Cajal body; cytoplasm; SMN complex; nucleus; Z disc; cytosol

Molecular Function: identical protein binding; protein binding; RNA binding

Biological Process: nervous system development; spliceosomal snRNP biogenesis; spliceosome assembly; gene expression

Disease: Spinal Muscular Atrophy, Type Ii; Spinal Muscular Atrophy, Type Iii; Spinal Muscular Atrophy, Type Iv; Spinal Muscular Atrophy, Type I